Anacor (ANAC) Approves 3.25M Common Offering
Up)
Anacor Pharmaceuticals (Nasdaq: ANAC), today announced the sale of 3.25 million shares of its common stock for gross proceeds of $21,450,000 pursuant to an underwriting agreement with Canaccord Genuity acting as the sole bookrunner. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 487,500 shares of common stock to cover over-allotments, if any.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- Regency Energy Partners (RGP) Files $200M Common Unit Shelf
- Corcept Therapeutics (CORT) Files 4.2M Common Shelf for Shareholders
- Rossetta Genomics (ROSG) Sells 570K Shares at $11.50/Sh
Create E-mail Alert Related Categories
Equity OfferingsRelated Entities
Genuity Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
